Bruce Robertson has joined THL Partners as a managing director on its healthcare investment team, coming from HIG Capital where he led investments in medical devices, digital health and diagnostics. At THL, Robertson will focus on medtech products, life science tools and diagnostics, sourcing and executing investments while supporting management teams.
Robertson’s prior investments include Intact Vascular, Vesper Medical, Apollo Endosurgery, Vertiflex, Neuwave Medical and Rx Sight, with several acquired by Philips, Boston Scientific and Johnson & Johnson. Before HIG, he was a managing director at Toucan Capital and a general partner at GIV Venture Partners, starting his career at WR Grace as an engineer.
THL has deployed more than $8.7 billion in healthcare, acquiring approximately 30 companies and supporting over 170 add-on acquisitions representing roughly $33 billion in aggregate enterprise value. The firm recently closed its tenth flagship fund with $6.35 billion in investable capital.
Joshua Nelson, head of healthcare at THL, said Robertson’s ability to assess both product technology and business opportunity will be a tremendous asset to the team and its partners.
Source: PE Hub · Summarized by HeadlinesBriefing